Dr Michelle Melisko discusses the challenging aspects involved in decision-making around screening for brain metastasis in ...

Enhertu maintained HRQOL and neurological function in HER2-positive metastatic breast cancer patients, regardless of brain ...

Ensartinib has received FDA approval for the first-line treatment of ALK-positive locally advanced or metastatic non–small ...

The Food and Drug Administration has approved Ensacove for patients with ALK-positive locally advanced or metastatic ...

Accuray Incorporated ARAY recently revealed findings from an international multicenter analysis, showing that the CyberKnife ...

The FDA approved ensartinib (Ensacove) as a first-line treatment for adults with ALK -positive locally advanced or metastatic ...

Recent cancer treatment breakthroughs include FDA approvals for zenocutuzumab and durvalumab, and sacituzumab tirumotecan gained breakthrough therapy status. In addition, sonodynamic therapy shows ...

Russia announces the development of an mRNA cancer vaccine, slated for a 2025 launch. Pre-clinical trials demonstrate tumor ...

Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that James ...

Accuray (ARAY) announced international retrospective multicenter analysis found that radiosurgery, or SRS, and fractionated ...

Fred Hutch graduate student Adam Nguyen has won a F31 training award from the NIH to study a complex molecule called Tie2 ...